{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:34:14Z","timestamp":1790786054628,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T00:00:00Z","timestamp":1667779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T00:00:00Z","timestamp":1667779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinik M\u00fcnchen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Rationale<\/jats:title>\n                <jats:p>Steroid profiles in combination with a corticotropin stimulation test provide information about steroidogenesis and its functional reserves in critically ill patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>We investigated whether steroid profiles before and after corticotropin stimulation can predict the risk of in-hospital death in sepsis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>An exploratory data analysis of a double blind, randomized trial in sepsis (HYPRESS [HYdrocortisone for PRevention of Septic Shock]) was performed. The trial included adult patients with sepsis who were not in shock and were randomly assigned to placebo or hydrocortisone treatment. Corticotropin tests were performed in patients prior to randomization and in healthy subjects. Cortisol and precursors of glucocorticoids (17-OH-progesterone, 11-desoxycortisol) and mineralocorticoids (11-desoxycorticosterone, corticosterone) were analyzed using the multi-analyte stable isotope dilution method (LC\u2013MS\/MS). Measurement results from healthy subjects were used to determine reference ranges, and those from placebo patients to predict in-hospital mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Measurements and main results<\/jats:title>\n                <jats:p>Corticotropin tests from 180 patients and 20 volunteers were included. Compared to healthy subjects, patients with sepsis had elevated levels of 11-desoxycorticosterone and 11-desoxycortisol, consistent with activation of both glucocorticoid and mineralocorticoid pathways. After stimulation with corticotropin, the cortisol response was subnormal in 12% and the corticosterone response in 50% of sepsis patients. In placebo patients (<jats:italic>n<\/jats:italic>\u2009=\u200990), a corticotropin-stimulated cortisol-to-corticosterone ratio\u2009&gt;\u200932.2 predicted in-hospital mortality (AUC 0.8 CI 0.70\u20130.88; sensitivity 83%; and specificity 78%). This ratio also predicted risk of shock development and 90-day mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In this exploratory analysis, we found that in sepsis mineralocorticoid steroidogenesis was more frequently impaired than glucocorticoid steroidogenesis. The corticotropin-stimulated cortisol-to-corticosterone ratio predicts the risk of in-hospital death.<\/jats:p>\n                <jats:p><jats:italic>Trial registration<\/jats:italic> Clinical trial registered with <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.clinicaltrials.gov\">www.clinicaltrials.gov<\/jats:ext-link> Identifier: NCT00670254. Registered 1 May 2008, <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00670254\">https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00670254<\/jats:ext-link>.\n<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13054-022-04224-5","type":"journal-article","created":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T14:02:32Z","timestamp":1667829752000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Corticotropin-stimulated steroid profiles to predict shock development and mortality in sepsis: From the HYPRESS study"],"prefix":"10.1186","volume":"26","clinical-trial-number":[{"clinical-trial-number":"nct00670254","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Josef","family":"Briegel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"M\u00f6hnle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Keh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna M.","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna C.","family":"Vetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Bogatsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothea","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludwig C.","family":"Hinske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djillali","family":"Annane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Vogeser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"SepNet Critical Care Trials Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Meybohm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Weigand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Gr\u00fcndling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"L\u00f6ffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kiehntopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Bloos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Elke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Meersch-Dini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Putensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim","family":"Kaasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kluge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,7]]},"reference":[{"key":"4224_CR1","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3389\/fendo.2016.00070","volume":"7","author":"D Annane","year":"2016","unstructured":"Annane D. The role of ACTH and corticosteroids for sepsis and septic shock: an update. Front Endocrinol (Lausanne). 2016;7:70.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"4224_CR2","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1001\/jama.283.8.1038","volume":"283","author":"D Annane","year":"2000","unstructured":"Annane D, S\u00e9bille V, Troch\u00e9 G, Rapha\u00ebl JC, Gajdos P, Bellissant E. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA: J Am Med Assoc. 2000;283(8):1038\u201345.","journal-title":"JAMA: J Am Med Assoc"},{"key":"4224_CR3","doi-asserted-by":"publisher","first-page":"104284","DOI":"10.1016\/j.ebiom.2022.104284","volume":"84","author":"G Van den Berghe","year":"2022","unstructured":"Van den Berghe G, T\u00e9blick A, Langouche L, Gunst J. The hypothalamus-pituitary-adrenal axis in sepsis- and hyperinflammation-induced critical illness: Gaps in current knowledge and future translational research directions. EBioMedicine. 2022;84:104284.","journal-title":"EBioMedicine"},{"issue":"12","key":"4224_CR4","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1007\/s00134-017-4914-x","volume":"43","author":"D Annane","year":"2017","unstructured":"Annane D, Pastores SM, Arlt W, Balk RA, Beishuizen A, Briegel J, Carcillo J, Christ-Crain M, Cooper MS, Marik PE, et al. Critical illness-related corticosteroid insufficiency (CIRCI): a narrative review from a Multispecialty Task Force of the Society of Critical Care Medicine (SCCM) and the European Society of Intensive Care Medicine (ESICM). Intensive Care Med. 2017;43(12):1781\u201392.","journal-title":"Intensive Care Med"},{"issue":"12","key":"4224_CR5","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1007\/s00134-018-5427-y","volume":"44","author":"B Peeters","year":"2018","unstructured":"Peeters B, Meersseman P, Vander Perre S, Wouters PJ, Debaveye Y, Langouche L, Van den Berghe G. ACTH and cortisol responses to CRH in acute, subacute, and prolonged critical illness: a randomized, double-blind, placebo-controlled, crossover cohort study. Intensive Care Med. 2018;44(12):2048\u201358.","journal-title":"Intensive Care Med"},{"issue":"10","key":"4224_CR6","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1007\/s00134-018-5366-7","volume":"44","author":"B Peeters","year":"2018","unstructured":"Peeters B, Meersseman P, Vander Perre S, Wouters PJ, Vanmarcke D, Debaveye Y, Billen J, Vermeersch P, Langouche L, Van den Berghe G. Adrenocortical function during prolonged critical illness and beyond: a prospective observational study. Intensive Care Med. 2018;44(10):1720\u20139.","journal-title":"Intensive Care Med"},{"issue":"6","key":"4224_CR7","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s00540-021-02977-x","volume":"35","author":"G Van den Berghe","year":"2021","unstructured":"Van den Berghe G. Adrenal function\/dysfunction in critically ill patients: a concise narrative review of recent novel insights. J Anesth. 2021;35(6):903\u201310.","journal-title":"J Anesth"},{"key":"4224_CR8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.mce.2014.11.012","volume":"408","author":"B Peeters","year":"2015","unstructured":"Peeters B, Boonen E, Langouche L, Van den Berghe G. The HPA axis response to critical illness: new study results with diagnostic and therapeutic implications. Mol Cell Endocrinol. 2015;408:235\u201340.","journal-title":"Mol Cell Endocrinol"},{"issue":"8","key":"4224_CR9","doi-asserted-by":"publisher","first-page":"E883","DOI":"10.1152\/ajpendo.00009.2014","volume":"306","author":"E Boonen","year":"2014","unstructured":"Boonen E, Meersseman P, Vervenne H, Meyfroidt G, Guiza F, Wouters PJ, Veldhuis JD, Van den Berghe G. Reduced nocturnal ACTH-driven cortisol secretion during critical illness. Am J Physiol Endocrinol Metab. 2014;306(8):E883-892.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"4224_CR10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/MED.0000000000000066","volume":"21","author":"E Boonen","year":"2014","unstructured":"Boonen E, Van den Berghe G. Cortisol metabolism in critical illness: implications for clinical care. Curr Opin Endocrinol Diabetes Obes. 2014;21(3):185\u201392.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"16","key":"4224_CR11","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1056\/NEJMoa1214969","volume":"368","author":"E Boonen","year":"2013","unstructured":"Boonen E, Vervenne H, Meersseman P, Andrew R, Mortier L, Declercq PE, Vanwijngaerden YM, Spriet I, Wouters PJ, Vander Perre S, et al. Reduced cortisol metabolism during critical illness. N Engl J Med. 2013;368(16):1477\u201388.","journal-title":"N Engl J Med"},{"issue":"3","key":"4224_CR12","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/0039-128X(74)90088-9","volume":"23","author":"CJ Nabors Jr","year":"1974","unstructured":"Nabors CJ Jr, West CD, Mahajan DK, Tyler FH. Radioimmunoassay of human plasma corticosterone: method, measurement of episodic secretion and adrenal suppression and stimulation. Steroids. 1974;23(3):363\u201378.","journal-title":"Steroids"},{"issue":"1","key":"4224_CR13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1365-2265.2006.02540.x","volume":"65","author":"PJ Raubenheimer","year":"2006","unstructured":"Raubenheimer PJ, Young EA, Andrew R, Seckl JR. The role of corticosterone in human hypothalamic-pituitary-adrenal axis feedback. Clin Endocrinol (Oxf). 2006;65(1):22\u20136.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"4224_CR14","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/ALN.0000000000003365","volume":"133","author":"GD Nethathe","year":"2020","unstructured":"Nethathe GD, Cohen J, Lipman J, Anderson R, Feldman C. Mineralocorticoid dysfunction during critical illness: a review of the evidence. Anesthesiology. 2020;133(2):439\u201357.","journal-title":"Anesthesiology"},{"key":"4224_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jpba.2017.12.045","volume":"151","author":"JM Lindner","year":"2018","unstructured":"Lindner JM, Suhr AC, Grimm SH, Mohnle P, Vogeser M, Briegel J. The dynamics of a serum steroid profile after stimulation with intravenous ACTH. J Pharm Biomed Anal. 2018;151:159\u201363.","journal-title":"J Pharm Biomed Anal"},{"issue":"17","key":"4224_CR16","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1001\/jama.2016.14799","volume":"316","author":"D Keh","year":"2016","unstructured":"Keh D, Trips E, Marx G, Wirtz SP, Abduljawwad E, Bercker S, Bogatsch H, Briegel J, Engel C, Gerlach H, et al. Effect of hydrocortisone on development of shock among patients with severe sepsis: The HYPRESS randomized clinical trial. JAMA. 2016;316(17):1775\u201385.","journal-title":"JAMA"},{"issue":"12","key":"4224_CR17","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1007\/s00134-009-1627-9","volume":"35","author":"J Briegel","year":"2009","unstructured":"Briegel J, Sprung CL, Annane D, Singer M, Keh D, Moreno R, M\u00f6hnle P, Weiss Y, Avidan A, Brunkhorst FM, et al. Multicenter comparison of cortisol as measured by different methods in samples of patients with septic shock. Intensive Care Med. 2009;35(12):2151\u20136.","journal-title":"Intensive Care Med"},{"issue":"3","key":"4224_CR18","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1620\/tjem.253.171","volume":"253","author":"MH Choi","year":"2021","unstructured":"Choi MH. Mass spectrometry-based steroid profiling: meeting unmet clinical needs. Tohoku J Exp Med. 2021;253(3):171\u201380.","journal-title":"Tohoku J Exp Med"},{"key":"4224_CR19","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1172\/JCI104091","volume":"39","author":"RE Peterson","year":"1960","unstructured":"Peterson RE, Pierce CE. The metabolism of corticosterone in man. J Clin Invest. 1960;39:741\u201357.","journal-title":"J Clin Invest"},{"key":"4224_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000134751","volume-title":"Disorders of the human adrenal cortex","author":"WL Miller","year":"2008","unstructured":"Miller WL. Steroidogenic enzymes. In: Fl\u00fcck CE, Miller WL, editors. Disorders of the human adrenal cortex, vol. 13. Basel: Karger; 2008. p. 1\u201318."},{"issue":"6","key":"4224_CR21","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1210\/er.2018-00262","volume":"40","author":"KH Storbeck","year":"2019","unstructured":"Storbeck KH, Schiffer L, Baranowski ES, Chortis V, Prete A, Barnard L, Gilligan LC, Taylor AE, Idkowiak J, Arlt W, et al. Steroid metabolome analysis in disorders of adrenal steroid biosynthesis and metabolism. Endocr Rev. 2019;40(6):1605\u201325.","journal-title":"Endocr Rev"},{"issue":"1","key":"4224_CR22","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4161\/viru.26907","volume":"5","author":"M Singer","year":"2014","unstructured":"Singer M. The role of mitochondrial dysfunction in sepsis-induced multi-organ failure. Virulence. 2014;5(1):66\u201372.","journal-title":"Virulence"},{"key":"4224_CR23","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1164\/rccm.202105-1197TR","volume":"205","author":"DA Hofmaenner","year":"2021","unstructured":"Hofmaenner DA, Kleyman A, Press A, Bauer M, Singer M. The many roles of cholesterol in sepsis: a review. Am J Respir Crit Care Med. 2021;205:388.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1\u20132","key":"4224_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.mce.2010.12.013","volume":"336","author":"W Kanczkowski","year":"2011","unstructured":"Kanczkowski W, Tymoszuk P, Chavakis T, Janitzky V, Weirich T, Zacharowski K, Ehrhart-Bornstein M, Bornstein SR. Upregulation of TLR2 and TLR4 in the human adrenocortical cells differentially modulates adrenal steroidogenesis. Mol Cell Endocrinol. 2011;336(1\u20132):41\u20136.","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"4224_CR25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/CCM.0b013e31822efa14","volume":"40","author":"CW Hicks","year":"2012","unstructured":"Hicks CW, Sweeney DA, Danner RL, Eichacker PQ, Suffredini AF, Feng J, Sun J, Behrend EN, Solomon SB, Natanson C. Efficacy of selective mineralocorticoid and glucocorticoid agonists in canine septic shock. Crit Care Med. 2012;40(1):199\u2013207.","journal-title":"Crit Care Med"},{"issue":"7","key":"4224_CR26","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1001\/jama.288.7.862","volume":"288","author":"D Annane","year":"2002","unstructured":"Annane D, Sebille V, Charpentier C, Bollaert P-E, Fran\u00e7ois B, Korach J-M, Capellier G, Cohen Y, Azoulay E, Troch\u00e9 G, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA: J Am Med Assoc. 2002;288(7):862\u201371.","journal-title":"JAMA: J Am Med Assoc"},{"issue":"9","key":"4224_CR27","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/NEJMoa1705716","volume":"378","author":"D Annane","year":"2018","unstructured":"Annane D, Renault A, Brun-Buisson C, Megarbane B, Quenot JP, Siami S, Cariou A, Forceville X, Schwebel C, Martin C, et al. Hydrocortisone plus fludrocortisone for adults with septic shock. N Engl J Med. 2018;378(9):809\u201318.","journal-title":"N Engl J Med"},{"issue":"8","key":"4224_CR28","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1590\/S0004-27302013000800009","volume":"57","author":"RB Moraes","year":"2013","unstructured":"Moraes RB, Friedman G, Viana MV, Tonietto T, Saltz H, Czepielewski MA. Aldosterone secretion in patients with septic shock: a prospective study. Arquivos Brasileiros de Endocrinologia & Metabologia. 2013;57(8):636\u201341.","journal-title":"Arquivos Brasileiros de Endocrinologia & Metabologia"},{"key":"4224_CR29","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3803\/EnM.2022.1549","volume":"37","author":"MH Choi","year":"2022","unstructured":"Choi MH. Clinical and technical aspects in free cortisol measurement. Endocrinol Metab (Seoul). 2022;37:599.","journal-title":"Endocrinol Metab (Seoul)"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-022-04224-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-022-04224-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-022-04224-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T14:03:20Z","timestamp":1667829800000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-022-04224-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,7]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["4224"],"URL":"https:\/\/doi.org\/10.1186\/s13054-022-04224-5","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,7]]},"assertion":[{"value":"30 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The trial protocol was approved by the responsible ethics committees of all 34 participating sites of the HYPRESS trial as listed in . The trial protocol is available at supplemental content 2 of reference (17).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"343"}}